Monday, 24 Feb 2020

Biologic/Novel Rx

Date Typesort ascending Title Save
29 Apr 2019 Social FDA has approved Samsung-Bioepsis biosimilar version of etanercept - Eticovo (etanercept-ykro), approved in other countries under names Benepali and Brenzys. Approval based on 596 RA pt trial w/ 52 wk ACR20 of 80.8% and 81.5% (Enbrel arm) https://t.co/r3q9dQ0Bdb
25 Feb 2019 Social ERRATA: "How to Handle Latex Allergies and Biologics" - has been corrected to show that the Cimzia PFS DOES contain 7% of a plastic derived from natural rubber latex. Latex- sensitive patients should be advised to handle the needle shield with caution. https://t.co/ThLns4C5Jt
05 Nov 2017 Social Year in Review. Dan Solomon reviews and shows no cancer risk with Biologics. #ACR17 https://t.co/wra8tf1viY
13 Jun 2016 Social GIACTA a landmark RCT proves tocilizumab works in #GCA: 52 wk TCZ more sustained remission, better steroid tapering https://t.co/zDvRrE8hmI
02 Aug 2018 Social Pfizers announces EU approval for tofacitinib 10 mg bid for use in adults with moderately to severely active ulcerative colitis (UC) who have had an inadequate response or intolerance to DMARD or biologic agents https://t.co/Cw9JFozphJ
15 Apr 2017 Social Will there be issues with BIOSIMILAR Safety, Switching or Cost? Patient survey: please vote 5 quick questions here https://t.co/LEcq7jSOzy
12 Jul 2018 Social RT @ByJonGardner: Some interesting insight on why US biosimilar uptake has been so anaemic from a Leerink note. Main reasons: PBMS lose mon…
29 Jul 2019 Social Measures used to limit costs & utilization of expensive biologics: 1) Generics 1st requirement; 2) Pre-authorization; 3) limited (6-9 mos) approval w/ proof of benefit; 4) 30 day supply; 5) preferred tiered drugs; & 6) utilize less expensive providers https://t.co/2HRrJn87AY
08 Nov 2017 Social RT @Janetbirdope: No difference in lung safety of Abatacept and TNFI and one study of more ILD with IFX vs ABA #137. #acr17 @rheumnow #526…
05 Dec 2017 Social FDA listing of currently approved BIOSIMILARS and their product info. 5 of 8 are for rheumatology, think you know them? https://t.co/5dQ0PI9klE
09 Aug 2016 Social In Japan, persistence on biologics highest in biologic-naïve (>95%) and older Pts & lowest w/ more comorbidities. https://t.co/4VTDOCpZeJ
01 Oct 2018 Social Hear nine experts talk about biosimilars in Therapeutic Update: Biosimilars, a video series brought to viewers by Sandoz. Now available on RheumNow. https://t.co/xyqelyCd2r #sponsored #biosimilars
03 May 2016 Social Simple patient article on new Remicade Biosimilar for RA, Psoriatic, Crohns, etc. But it wont be available till 2017 https://t.co/58SZ335Doq
18 May 2017 Social RT @DrPetryna: @RheumNow could ustekinumab potentially be used in treatment of refractory GCA? Evidence suggests it might https://t.co/Ydr0…
25 Jun 2015 Social Antecdotal reports of tofacitinib success in resolving depigmentation of vitiligo. http://t.co/SuxoawAbma
25 May 2017 Social RT @RWCSmtg: NOR-SWITCH trial suggests Remicade Can Be Substituted for Less Expensive Biosimilar CT-P13 https://t.co/oTpLD9Qymf #psoriasis…
24 Jan 2017 Social FDA has granted priority review designation for use of tocilizumab in giant cell artertitis based on GiACTA study https://t.co/qOeYvZnc9p
22 Feb 2018 Social https://t.co/ru9Ej9aMDu of Derm mtg in San Diego has several new biologic therapies of Atopic Dermatitis, including baricitinib, upadacitinib, ASN002 (JAK/SYK inhibitor) and anti IL-33 (ANB020). https://t.co/cOm6jcPRCq
28 Sep 2016 Social Yale study of Alopecia (areata or universalis) showed 32% of 66pts improved with tofacitinib 5mg bid after 3 months. https://t.co/DBmnWEujiM
25 Oct 2018 Social RT @WIRheum: Canabinoids in vitro CB2 receptor drives inflammation Set the stage for discovery/development of future antagonists? Danger…